SCHEMBL7364869

SCHEMBL7364869

O=C(O)CCc1cc(-c2nc3cc(Cl)c(Cl)cc3[nH]c2=O)cc([N+](=O)[O-])c1CCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 5/20 0.47
PRKAA2 P54646 5/20 0.47
PRKAB1 Q9Y478 5/20 0.47
PRKAA1 Q13131 1/20 0.47
GRIA2 P42262 2/20 0.41
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
LMNA P02545 1/20 0.41
GRIK1 P39086 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41
GRIK2 Q13002 1/20 0.41
GRIK3 Q13003 1/20 0.41
GRIK4 Q16099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371644 0.77 ALDH1A1 (0.47) GRIA2FBP1
SCHEMBL7369543 0.77 KDM4E (0.44) LMNAFBP1NPC1MAPTRAB9A
SCHEMBL7369598 0.76 GRIN2D (0.47) GRIA2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8726072 0.74 CETP (0.39) GRIA2LMNAFBP1
SCHEMBL7364700 0.72 MMP2 (0.48) LMNAFBP1NPC1MAPTRAB9A
SCHEMBL8731797 0.70 DAGLA (0.43) LMNAFBP1NPC1MAPTRAB9A
SCHEMBL7371645 0.70 DAGLA (0.43) LMNAFBP1NPC1MAPTRAB9A
SCHEMBL6659871 0.70 PRKAG1 (0.68) PRKAG1PRKAA2PRKAB1PRKAA1GRIA2
SCHEMBL8726189 0.69 MAPT (0.53) LMNAFBP1NPC1MAPTRAB9A
SCHEMBL7367829 0.69 MAPT (0.53) LMNAFBP1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed